Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
about
Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampusClozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments.Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle responseComparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain traumaThe natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance.Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brainAdministration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficitsUse of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonistsAmeliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling.Catha edulis chewing effects on treatment of paranoid schizophrenic patientsNeuroleptic treatment of agitation and psychosis in dementia.Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain.Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil.Contribution of the nucleus accumbens to cocaine-induced responses of ventral pallidal neurons.Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function.Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's diseaseDouble dissociation of dopamine genes and timing in humans.Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum.Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats.Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats.In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.Low dose risperidone attenuates cue-induced but not heroin-induced reinstatement of heroin seeking in an animal model of relapse.Developmental GABAergic deficit enhances methamphetamine-induced apoptosis.Enhancement of latent inhibition in the rat at a high dose of clozapine.Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience
P2860
Q28572389-21844D03-9B18-4C40-B329-B8E388EB4D48Q30370324-1D5032CF-8AD4-4410-9E77-A465FA1CF1F5Q30406145-C9C0D5C3-C22C-4B0D-98BE-B7C9791E8E16Q30546301-634181EB-439E-4EB0-98E7-CD9489E04FD8Q34169978-38B36C9B-4329-4DBB-899F-2B615C155793Q34522683-E9F05960-B576-4DE1-B7F5-D68FC274E7DFQ34523361-6AC0E978-E720-4F18-ADE8-001D02002D75Q34635707-832E369C-AF36-4BBC-A945-86FB21B18A1EQ34660497-A3D6186A-B298-43C3-9C0E-0026430EFB0FQ34970798-9A0F12B6-1711-494C-AFE4-81061A65F071Q35529642-824D3D76-824D-444E-90CA-3E7CE48D64DDQ35994829-C2326E48-7304-4708-9970-0A57A46BF2FCQ36338174-9EAD569A-3E4B-407F-ACC5-BDD83071D4D5Q37018684-09CD1230-7278-40DD-9DE3-AA6E433A5199Q37230899-3E761B4E-3F41-4CFE-8FEF-1668F85DBA04Q37249390-8981C67B-D843-4AFF-B6D1-CFAB10A477E4Q39802850-9DBBB981-9E58-499E-A23B-E239F2F061D6Q40945355-C094B262-B472-4E34-A3C9-ECF2A6198CE3Q41111202-73CB3640-D205-47BF-8A0E-174D957ACA5AQ41861355-9225D716-0595-425D-916A-474AA5BDA1DDQ42130086-6D38EE08-8F7F-48C5-A02E-347A4159EEFDQ42437753-34442461-186D-4376-BA09-823D23B0C516Q42482728-55EA6C68-97D7-451A-A9F5-8CC717C8F920Q42501591-77E5E4D6-E61F-482A-AAF8-DF1C09D20B81Q42689688-66CF4720-2E0C-4B2F-AA83-40F6383C14F0Q43513506-815A30ED-A774-4DB3-8C80-54412AF1D8FDQ43910663-32B66CB5-53DC-4DA8-A0D1-FD9F6524C633Q44169297-F983523C-922A-4178-A24F-E512F22E9328Q44357525-9DDDE4E9-4B57-46C3-B717-DEA8A05069D6Q47633556-091063BD-A528-4DC3-9AD6-52D8D0FF2E24Q48189500-42F87C8C-4A34-4029-BC88-05E16C82AB63Q48224639-D8BF084E-B3EF-4ABB-AC22-EA942A03BF94Q48345571-B13E77C4-90CD-48B0-BAC0-BA8A69AF1D5AQ48461344-41CC4F6D-0F73-4580-BF26-3802190C1DF9Q48644876-24A8AECF-E274-4F72-806B-72E6B6712E11Q48903035-950D6428-A1BA-4F40-A259-22048F5E049AQ50764331-29B5CFBE-31B9-4E5E-BFDA-657DD840BEA2Q51871366-3FC06159-07EE-415E-B207-9B65DC120E1AQ52185494-E9161DAB-DFDD-4C0C-BF85-ACBF040B0003Q57169426-8229EF6C-C54E-4BBB-A779-C68927F231AA
P2860
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
Occupancy of central neurotran ...... quantitative autoradiography.
@ast
Occupancy of central neurotran ...... quantitative autoradiography.
@en
Occupancy of central neurotran ...... quantitative autoradiography.
@nl
type
label
Occupancy of central neurotran ...... quantitative autoradiography.
@ast
Occupancy of central neurotran ...... quantitative autoradiography.
@en
Occupancy of central neurotran ...... quantitative autoradiography.
@nl
prefLabel
Occupancy of central neurotran ...... quantitative autoradiography.
@ast
Occupancy of central neurotran ...... quantitative autoradiography.
@en
Occupancy of central neurotran ...... quantitative autoradiography.
@nl
P2093
P1433
P1476
Occupancy of central neurotran ...... quantitative autoradiography.
@en
P2093
P304
P356
10.1016/0006-8993(93)91535-Z
P407
P577
1993-12-01T00:00:00Z